Verum Pharmaceuticals

Verum Pharmaceuticals appears to be a small pharmaceutical company name used by at least two legal entities, including a U.S. entity in North Carolina and an Indian private company in Assam. Publicly available evidence for the U.S. entity indicates commercial activity around marketed cough-and-cold products rather than an innovative clinical-stage biotech pipeline. The clearest product attribution found is Bromfed DM cough syrup, a combination product containing brompheniramine, dextromethorphan, and pseudoephedrine. There is no reliable evidence of a proprietary R&D platform, novel therapeutic pipeline, or active clinical development programs. Because the name maps to multiple entities and the public record is sparse, this profile should be treated as a low-confidence commercial pharma/company identification rather than a fully validated biotech company dossier.